Welcome to the official website of Unipharm pharmaceutical industry Co., Ltd.！
Focus on research and development of new active pharmaceutical ingredients, pharmaceutical intermediates, APIs and other specialty chemicals
Pharmaceutical Intermediates Heterocyclic Block Organic Block
Home> Pharmaceutical Intermediates>Antineoplastic Agents> Sunitinib Intermediate
Sunitinib Is An Oral, Small-Molecule, Multi-Target Receptor Tyrosine Kinase (Rtk) Inhibitor, Targeting Both Vegfr2 And Pdgfrbeta With Ic50 Values Of 80 Nm And 2 Nm, Respectively.
No data
